ERXI WU to Protein Kinase Inhibitors
This is a "connection" page, showing publications ERXI WU has written about Protein Kinase Inhibitors.
Connection Strength
0.122
-
Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-?B pathways with novel theanine derivatives. Oncotarget. 2014 Sep 30; 5(18):8528-43.
Score: 0.080
-
Src/FN1 pathway activation drives tumor cell cluster formation and metastasis in lung cancer: A promising therapeutic target. Sci Adv. 2025 Jul 11; 11(28):eadv7377.
Score: 0.042